Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Alternative RNA Splicing

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...

The Equilibrium Binding Constant and Binding Strength

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:

Types of Toxins

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...

Drug Distribution: Plasma Protein Binding

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...

Protein-Drug Binding: Determination Methods

Protein-Drug Binding: Determination Methods

Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Controlled immobilization of single-domain antibodies using cellulose-binding modules for AB<sub>5</sub>-type toxin detection in paper-based assays.

RSC advances·2026

Same author

A Framework for Database Search with AI Models in Mass Spectrometry-Based Proteomics.

Journal of proteome research·2026

Same author

InstaNovo enables diffusion-powered de novo peptide sequencing in large-scale proteomics experiments.

Nature machine intelligence·2026

Same author

An mRNA-delivered consensus allergen induces a neutralizing IgG response against food and pollen allergens.

Nature communications·2026

Same author

Improved protein binder design using β-pairing targeted RFdiffusion.

Nature communications·2026

Same author

Attenuating ETEC virulence using a heat-labile enterotoxin-blocking binding protein.

Gut microbes·2025

Same journal

Chemical, Biological, and Ecological Evidence for Aerobic Deoxynivalenol Detoxification in Agronomic Soil-Derived Bacterial Communities.

Toxins·2026

Same journal

Botulinum Toxin Treatment for Uncommon Phenotypes of Laryngeal Adductor Breathing Dystonia.

Toxins·2026

Same journal

Enhancing Neuronal Networks with <i>Rhinella schneideri</i> Skin Secretion Molecules: Implications for Neurodegenerative Disorders.

Toxins·2026

Same journal

Dangerous Measures: A Case Report and Review of Motoro Ray Envenomation.

Toxins·2026

Same journal

The Impact of OnabotulinumtoxinA on Oral Pain Medication Prescription Fills and Low-Value Care in Patients with Cervical Dystonia in the United States: A Retrospective Claims Analysis.

Toxins·2026

Same journal

Broad-Spectrum Antiviral and Antibacterial Activity of the Scorpion Venom Peptide HP1090.

Toxins·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 30, 2026

Toxin Induction and Protein Extraction from Fusarium spp. Cultures for Proteomic Studies

Toxin Induction and Protein Extraction from Fusarium spp. Cultures for Proteomic Studies

Published on: February 16, 2010

Toxin Neutralization Using Alternative Binding Proteins.

Timothy Patrick Jenkins¹, Thomas Fryer², Rasmus Ibsen Dehli³

¹Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, UK. tpj24@cam.ac.uk.

|January 20, 2019

Summary

This summary is machine-generated.

New protein scaffolds offer promising, low-cost alternatives to traditional antivenoms for treating snakebite envenoming, potentially improving global accessibility and efficacy against dangerous animal toxins.

Keywords:

Snakebite envenoming alternative binding protein scaffolds envenoming therapy next-generation antivenom recombinant binding proteins toxin neutralization venom neutralization

More Related Videos

Pull-down of Calmodulin-binding Proteins

Pull-down of Calmodulin-binding Proteins

Published on: January 23, 2012

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

Related Experiment Videos

Last Updated: Jan 30, 2026

Toxin Induction and Protein Extraction from Fusarium spp. Cultures for Proteomic Studies

Toxin Induction and Protein Extraction from Fusarium spp. Cultures for Proteomic Studies

Published on: February 16, 2010

Pull-down of Calmodulin-binding Proteins

Pull-down of Calmodulin-binding Proteins

Published on: January 23, 2012

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

Area of Science:

Biochemistry
Immunology
Toxicology

Background:

Snakebite envenomings cause over 100,000 deaths annually, with plasma-derived antivenom as the sole treatment.
Current antivenoms have limitations including immunogenicity and high production costs.
Alternative binding protein scaffolds are being explored to overcome these limitations.

Purpose of the Study:

To review various alternative binding protein scaffolds.
To discuss their potential as next-generation antivenoms.
To highlight their advantages over traditional antivenoms.

Main Methods:

Review of existing literature on binding protein scaffolds.
Analysis of different scaffold types (e.g., nanobodies, DARPins, affibodies).
Discussion of their biochemical and pharmacokinetic properties.

Main Results:

A variety of alternative protein scaffolds exist, including antibody derivatives and engineered proteins.
These scaffolds offer potential advantages such as high stability and lower production costs.
Their engineerability makes them suitable for developing novel therapeutics.

Conclusions:

Alternative binding protein scaffolds show significant promise for developing next-generation antivenoms.
These novel therapeutics could offer more accessible and effective treatments for snakebite envenoming.
Further investigation into these scaffolds is warranted for their therapeutic potential.